CXS 0.00% 70.0¢ chemgenex pharmaceuticals ltd

The FDA can be real obstructionist. Have a look at what they did...

  1. 682 Posts.
    lightbulb Created with Sketch. 6
    The FDA can be real obstructionist. Have a look at what they did to another Australian Company, Pharmasix, late last year:

    First the FDA Advisory Committe recommenda approval on 26/11/09: http://www.hotcopper.com.au/asx_announcements.asp?id=115850

    Then the FDA disapprove on 29/12/09: http://www.hotcopper.com.au/asx_announcements.asp?id=135361


    My personal interpretation of the FDA request from CXS is that they come up with a validated test that identifies the test patients that have (or had) the T31521 mutation. Then they have to correlate this with the clinical test results CXS already establlished. I don't believe any further testing or retesting is required. Sounds simple but CXS will have to get this 101% right to satisfy the FDA.

    It will probably take a few months. Investors (or speculators) have become very impatient and don't fully understand the FDA's request. A few reassuring bulletins from CXA management would stabilise the share price, but it's clear to me that communication is not their forte.

 
watchlist Created with Sketch. Add CXS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.